Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Low Number of Detectable Circulating Tumor Cells in Non-metastatic Colon Cancer

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{17007eccbbee43109d6b21054121f4a2,
title = "Low Number of Detectable Circulating Tumor Cells in Non-metastatic Colon Cancer",
abstract = "The aim of the present study was to detect circulating tumor cells (CTCs) in the peripheral blood of patients with non-metastatic colon cancer and to evaluate whether there is a diurnal variation in the CTC counts. Furthermore, the study aimed to examine the correlation between CTCs and TNM stage, other paraclinical variables and prognosis.",
author = "Morten Thorsteinsson and Gy{\"o}rgy S{\"o}letormos and Per Jess",
year = "2011",
month = "2",
day = "1",
language = "English",
volume = "31",
pages = "613--7",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "2",

}

RIS

TY - JOUR

T1 - Low Number of Detectable Circulating Tumor Cells in Non-metastatic Colon Cancer

AU - Thorsteinsson, Morten

AU - Söletormos, György

AU - Jess, Per

PY - 2011/2/1

Y1 - 2011/2/1

N2 - The aim of the present study was to detect circulating tumor cells (CTCs) in the peripheral blood of patients with non-metastatic colon cancer and to evaluate whether there is a diurnal variation in the CTC counts. Furthermore, the study aimed to examine the correlation between CTCs and TNM stage, other paraclinical variables and prognosis.

AB - The aim of the present study was to detect circulating tumor cells (CTCs) in the peripheral blood of patients with non-metastatic colon cancer and to evaluate whether there is a diurnal variation in the CTC counts. Furthermore, the study aimed to examine the correlation between CTCs and TNM stage, other paraclinical variables and prognosis.

M3 - Journal article

VL - 31

SP - 613

EP - 617

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 2

ER -

ID: 31038599